CSL wins approval to buy Vifor Pharma in EU
MLex Summary: Australian biotechnology company CSL has received the European Commission's clearance to acquire Swiss pharmaceutical company Vifor Pharma. The commission said late yesterday that the deal wouldn't raise antitrust concerns, due...To view the full article, register now.
Already a subscriber? Click here to view full article